Main business and products
Taiji Group is mainly engaged in the production and sales of Chinese and western medicines, including Chinese patent medicines, western medicines and health foods. Among them, the well-known products are Huoxiang Zhengqi Oral Liquid, Tailuo, Jizhi Syrup, Erkangning, Bushen Yishou Capsule and so on.
Taiji Group has transformed production technology into productivity and made a qualitative leap. The largest syrup production line in Asia, with an annual output of 654.38 billion bottles; The largest oral liquid production line in China, with an annual output of 654.38+0 billion; The largest Chinese herbal medicine pretreatment workshop and extraction and concentration workshop in China, with an annual extraction capacity of 654.38+10,000 tons; China's first GMP mode production workshop freeze-dried powder injection production line; It has the most advanced bottle-making production line in Japan, soft bag infusion production line in Germany, automatic granule production line in Canada and automatic packaging production line in Italy.
Business performance and market position
In the first quarter of 2024, Taiji Group achieved a net profit of 247 million yuan, a year-on-year increase of 5.05%. The overall financial situation of the company is good, showing steady growth ability and excellent operation ability.
20 1 September 91,20 19 released the Top 500 Chinese Enterprises, and Taiji Group ranked 380th; 20 19 The list of the top 500 manufacturing enterprises in China was released, and Taiji Group Co., Ltd. ranked 180. 20 19 12 13, 20 19 Chongqing Top 65438 list was released, and Taiji Group Co., Ltd. ranked 14.
On June 28th, 2022, 65438 National Development and Reform Commission and other departments issued a notice on printing and distributing 202 1 (the 28th batch) and the list of all state-level enterprise technology centers, which showed that the enterprise technology center was qualified as a state-level enterprise technology center.
Scientific research and innovation
Taiji Group has a strong scientific research system, which consists of R&D institutions such as Chongqing Institute of Traditional Chinese Medicine and Taiji Medicine Research Institute. The Group has made remarkable achievements in the research and development of new drugs, forming a benign pattern of development generation, research generation and reserve generation. At present, Taiji Group owns more than 50,000 varieties of Chinese and western medicines 1.05, of which more than 50 varieties are exclusively produced and obtained national patents 1.08.
Corporate culture and social responsibility
Taiji Group adheres to the corporate philosophy of "protecting life and caring for health" and the corporate mission of "invigorating the country with Chinese medicine and helping the poor with Taiji". The group is committed to becoming a world-class Chinese medicine enterprise, and adheres to the core values of "bringing forth the old and bringing forth the new, striving for perfection". While pursuing economic benefits, Taiji Group also actively fulfills its social responsibilities and contributes to social health.